Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Neutropenia
Interventions: BIOLOGICAL: Pegylated Recombinant Human G-CSF|BIOLOGICAL: GW003
Sponsor: Jiangsu T-Mab Biopharma Co.,Ltd